Ocrevus

Biotechs Find Strength In Numbers In Treating Multiple Sclerosis
Investors Business Daily
Fri, 07/21/17 - 10:25 am
MS
multiple sclerosis
Roche
Celgene
Novartis
Biogen
ozanimod
Gilenya
Ocrevus
Extavia
Roche's Ocrevus racks up more positive MS data in relapsing and primary progressive forms
Fierce Pharma
Sat, 06/24/17 - 09:14 am
Roche
Ocrevus
MS
multiple sclerosis
Prescribed Reading: FDA on a roll, while pharma continues sell off
BioPharma Dive
Tue, 05/30/17 - 10:07 am
FDA
Roche
Ocrevus
Puma Biotechnology
neratinib
Novartis
Roche looks into PML report for Ocrevus patient
BioPharma Dive
Thu, 05/25/17 - 11:25 am
Roche
PML
Ocrevus
Genentech
MS
multiple sclerosis
4 Reasons Why Roche Will Have the Best Growth in Big Pharma... and 1 Reason Why It Won't
Motley Fool
Wed, 04/12/17 - 10:33 am
Roche
Tecentriq
Perjeta
HER-2 postive breast cancer
Ocrevus
MS
multiple sclerosis
diagnostics
generics
biosimilars
Why Roche's New Drug Is Bad News For Biogen
Barron's
Sun, 04/9/17 - 12:20 pm
Roche
Biogen
Ocrevus
multiple sclerosis
MS
Tysabri
Tecfidera
Roche secures FDA approval for Ocrevus for two types of MS
BioPharma Dive
Tue, 03/28/17 - 11:56 pm
Roche
Ocrevus
FDA
ocrelizumab
MS
multiple sclerosis
Crunch week looms for Sanofi, Roche and GSK at U.S. drugs agency
Yahoo/Reuters
Thu, 03/23/17 - 09:32 am
Sanofi
Roche
GSK
FDA
Ocrevus
MS
Dupixent
eczema
generics
Advair
Mylan Labs
Roche touts efficacy of MS drug despite delays
BioPharma Dive
Tue, 12/27/16 - 10:16 am
Roche
MS
multiple sclerosis
Ocrevus
ocrelizumab
FDA pushes decision on Roche MS drug to March
BioPharma Dive
Wed, 12/21/16 - 11:13 am
FDA
Roche
MS
multiple sclerosis
Ocrevus
ocrelizumab
If Roche's Ocrevus is approved, the already competitive MS market will gain another player
Medical Marketing and Media
Mon, 10/24/16 - 11:54 pm
Roche
Ocrevus
MS
multiple sclerosis

Pages